PHGDH and Alzheimer disease: The increased PHGDH expression in AD models and patients brain tissues (e.g., 1.5–2.5-fold increase in AD mouse models and 1.54-fold in the hippocampus of AD patients) (Chen et al., 2022; Maffioli et al., 2022), supports the notion that the PP is modulated in pathological conditions.